News Sentiment

ELDN sentiment intelligence

Eledon Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 38 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.85 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 30

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-2.5% over one week, +7.8% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Natera (NTRA) Partners With Eledon To Put Prospera Into Phase 3 Kidney Trial

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -2.5% Price reacting lower
Trend fit Trend active 7.8% over four weeks
Fair value 42.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 30
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 30
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
simplywall.st 7
GlobeNewswire 3
Investing.com 3
MT Newswires 2
Stock Titan 2
Business Wire 1
Seeking Alpha 1

Event Lens

What the news is about

Classified themes
Earnings 17
Market update 17
Deals and strategy 2
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-38 of 38